4th Quarter - Report
S-3 GROUP for AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC.
Firm
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Foreign entity interest: Issues listed in Line 16 directly affect the business interests of Horizon Pharma PLC.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN CASEY | Senior Pol Dir, Dem Caucus; Counselor, Leg. Dir, Leg. Asst, Rep. Joseph Crowley; Staff Asst, Leg. Correspondent, Rep. Bob Weygand |
| MICHAELEEN EARLE CROWELL | Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders |
| MARTIN DELGADO | Staff Director, House Ag Approps; Professional Staff, MilCon/VA Approps, Budget Analyst APHIS |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| HORIZON PHARMA PLC | Ireland | Ireland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.